Patents by Inventor Martin R. LEIVERS

Martin R. LEIVERS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY FOR TREATING HEPATITIS B VIRUS INFECTIONS
    Publication number: 20250092401
    Abstract: The present disclosure is related to methods for treating hepatitis B infections. The methods comprising administering a subject in need thereof a PAPD5/7 inhibitor and a modified ASO that targets HBV mRNAs.
    Type: Application
    Filed: January 26, 2023
    Publication date: March 20, 2025
    Inventors: Jared Loren DELAHAYE, Martin R. LEIVERS, Malek OKOUR, Shihyun Kieffer YOU
  • 5,6,7,7a-Tetrahydrocyclopenta[f]pyrido[1,2-h][1,7] naphthyridin-11(4bH)-one Compounds and Methods of use Use (as amended)
    Publication number: 20250066361
    Abstract: Compounds, specifically hepatitis B virus and/or hepatitis D virus inhibitors, more specifically compounds that inhibit HBe antigen and HBs antigen in a subject, for the treatment of viral infections, and methods of preparing and using such compounds.
    Type: Application
    Filed: November 11, 2024
    Publication date: February 27, 2025
    Inventors: John G. CATALANO, Pek Yoke Chong, Hamilton D. Dickson, Martin R. Leivers, Jason Gordon Weatherhead
  • 5,6,7,7a-tetrahydrocyclopenta[f]pyrido[1,2-h][1,7]naphthyridin-11(4bH)-one compounds and methods of use
    Patent number: 12221444
    Abstract: Compounds, specifically hepatitis B virus and/or hepatitis D virus inhibitors, more specifically compounds that inhibit HBe antigen and HBs antigen in a subject, for the treatment of viral infections, and methods of preparing and using such compounds.
    Type: Grant
    Filed: October 25, 2021
    Date of Patent: February 11, 2025
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: John G. Catalano, Pek Yoke Chong, Hamilton D. Dickson, Martin R. Leivers, Jason Gordon Weatherhead
  • Chemical Compounds
    Publication number: 20220144834
    Abstract: Compounds, specifically hepatitis B virus and/or hepatitis D virus inhibitors, more specifically compounds that inhibit HBe antigen and HBs antigen in a subject, for the treatment of viral infections, and methods of preparing and using such compounds.
    Type: Application
    Filed: October 25, 2021
    Publication date: May 12, 2022
    Inventors: John G. CATALANO, Pek Yoke CHONG, Hamilton D. DICKSON, Martin R. LEIVERS, Jason Gordon WEATHERHEAD
  • CHEMICAL COMPOUNDS
    Publication number: 20200255428
    Abstract: Compounds, specifically hepatitis B virus and/or hepatitis D virus inhibitors, more specifically compounds that inhibit HBe antigen and HBs antigen in a subject, for the treatment of viral infections, and methods of preparing and using such compounds.
    Type: Application
    Filed: October 5, 2018
    Publication date: August 13, 2020
    Applicant: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: John G. CATALANO, Pek Yoke CHONG, Hamilton D. DICKSON, Martin R. LEIVERS, Jason Gordon WEATHERHEAD
  • Combination long acting compositions and methods for Hepatitis C
    Patent number: 10308937
    Abstract: The present Invention relates to pharmaceutical compositions useful in the treatment or prevention or cure of viral infections, such as HCV infections, and diseases associated with such infections.
    Type: Grant
    Filed: October 30, 2015
    Date of Patent: June 4, 2019
    Assignee: GlaxoSmithKline Intellectual Property (No. 2) Limited
    Inventors: Zhi Hong, Martin R. Leivers
  • LONG ACTING PHARMACEUTICAL COMPOSITIONS FOR HEPATITIS C
    Publication number: 20170333460
    Abstract: The present Invention relates to Pharmaceutical compositions useful in the treatment or prevention or cure of viral infections, such as HCV infections, and diseases associated with such infections.
    Type: Application
    Filed: October 30, 2015
    Publication date: November 23, 2017
    Inventors: Zhi HONG, Martin R. LEIVERS
  • COMBINATION LONG ACTING COMPOSITIONS AND METHODS FOR HEPATITIS C
    Publication number: 20170314022
    Abstract: The present Invention relates to pharmaceutical compositions useful in the treatment or prevention or cure of viral infections, such as HCV infections, and diseases associated with such infections.
    Type: Application
    Filed: October 30, 2015
    Publication date: November 2, 2017
    Inventors: Zhi HONG, Martin R. LEIVERS
  • Long Acting Pharmaceutical Compositions For Hepatitis C
    Publication number: 20170312297
    Abstract: The present Invention relates to long acting pharmaceutical compositions useful in the treatment or prevention or cure of viral infections, such as HCV infections, and diseases associated with such infections.
    Type: Application
    Filed: October 30, 2015
    Publication date: November 2, 2017
    Applicant: Glaxosmithkline Intellectual Property (NO. 2) Limited
    Inventors: Zhi HONG, Martin R. LEIVERS